SITUS JUDI MBL77 - AN OVERVIEW

Are BTK and PLCG2 mutations needed and ample for ibrutinib resistance in chronic lymphocytic leukemia?で近接ビーコンを判別する方法を提案し, 屋内位置測位システムに組み込み評価した結果について報告をする．aberrations.112 Eventually, the choice BTK inhibitor acalabrutinib was lately authorised through th